|
Tunitas Therapeutics Awarded Phase II SBIR Grant to Advance Asthma Program
PR Newswire (press release) SAN FRANCISCO, June 4, 2013 /PRNewswire/ — Tunitas Therapeutics, Inc., a private company discovering and developing novel human fusion proteins for the treatment of asthma and other allergic diseases, has been awarded a Small Business Innovation … |
View full post on asthma – Google News